JP Morgan Chase’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.5M Sell
285,000
-69,200
-20% -$5.18M ﹤0.01% 2103
2025
Q4
$28M Buy
354,200
+205,300
+138% +$16.2M ﹤0.01% 1781
2025
Q3
$12.3M Sell
148,900
-11,100
-7% -$874K ﹤0.01% 2538
2025
Q2
$12.9M Sell
160,000
-300
-0.2% -$23.1K ﹤0.01% 2329
2025
Q1
$12.9M Sell
160,300
-158,300
-50% -$13.2M ﹤0.01% 2322
2024
Q4
$26.1M Sell
318,600
-264,000
-45% -$22M ﹤0.01% 1792
2024
Q3
$48.1M Buy
582,600
+485,000
+497% +$36.2M ﹤0.01% 1353
2024
Q2
$6.85M Sell
97,600
-26,900
-22% -$1.92M ﹤0.01% 2786
2024
Q1
$9.23M Sell
124,500
-117,700
-49% -$8.2M ﹤0.01% 2562
2023
Q4
$16M Hold
242,200
﹤0.01% 2028
2023
Q3
$15.2M Sell
242,200
-96,000
-28% -$5.98M ﹤0.01% 1897
2023
Q2
$19.1M Buy
338,200
+25,500
+8% +$1.42M ﹤0.01% 1732
2023
Q1
$18.1M Buy
312,700
+244,700
+360% +$16.5M ﹤0.01% 1750
2022
Q4
$4.92M Buy
68,000
+26,200
+63% +$1.88M ﹤0.01% 2825
2022
Q3
$2.54M Sell
41,800
-35,200
-46% -$2.25M ﹤0.01% 3277
2022
Q2
$4.83M Buy
77,000
+14,900
+24% +$986K ﹤0.01% 2818
2022
Q1
$4.36M Sell
62,100
-5,300
-8% -$358K ﹤0.01% 3126
2021
Q4
$4.21M Hold
67,400
﹤0.01% 3211
2021
Q3
$4.16M Buy
67,400
+3,200
+5% +$193K ﹤0.01% 3189
2021
Q2
$3.84M Buy
+64,200
New +$4.07M ﹤0.01% 3281
2021
Q1
Sell
-65,500
Closed -$3.08M 6227
2020
Q4
$3.08M Sell
65,500
-84,800
-56% -$3.67M ﹤0.01% 3180
2020
Q3
$5.53M Buy
150,300
+109,100
+265% +$4.14M ﹤0.01% 2489
2020
Q2
$1.5M Sell
41,200
-67,700
-62% -$2.36M ﹤0.01% 3288
2020
Q1
$3.33M Sell
108,900
-422,900
-80% -$18.8M ﹤0.01% 2581
2019
Q4
$27.1M Sell
531,800
-790,100
-60% -$38.1M 0.01% 1351
2019
Q3
$62.3M Buy
1,321,900
+1,025,000
+345% +$48.9M 0.01% 839
2019
Q2
$14.6M Buy
296,900
+221,800
+295% +$10.4M ﹤0.01% 1808
2019
Q1
$3.2M Sell
75,100
-88,130
-54% -$3.9M ﹤0.01% 2967
2018
Q4
$6.7M Sell
163,230
-597,300
-79% -$25.6M ﹤0.01% 2338
2018
Q3
$35.5M Buy
760,530
+344,700
+83% +$15.8M 0.01% 1237
2018
Q2
$18.1M Buy
415,830
+198,000
+91% +$9.23M ﹤0.01% 1669
2018
Q1
$10M Sell
217,830
-271,519
-55% -$13.2M ﹤0.01% 2034
2017
Q4
$24.7M Buy
489,349
+420,649
+612% +$22.2M 0.01% 1421
2017
Q3
$3.53M Sell
68,700
-488,822
-88% -$23.8M ﹤0.01% 2818
2017
Q2
$27.3M Buy
557,522
+111,137
+25% +$5.16M 0.01% 1245
2017
Q1
$21M Sell
446,385
-78,038
-15% -$3.72M ﹤0.01% 1440
2016
Q4
$25.2M Buy
524,423
+241,305
+85% +$11.1M 0.01% 1311
2016
Q3
$11.2M Buy
+283,118
New +$10.6M ﹤0.01% 1717
2016
Q2
Sell
-16,830
Closed -$659K 4886
2016
Q1
$659K Buy
+16,830
New +$629K ﹤0.01% 3244

Other funds holding MET

JP Morgan Chase's MET Position: Q1 2026 in Review

JP Morgan Chase reduced its MetLife (MET) stake by 8.7% in Q1 2026, selling an estimated $24.6M and leaving 3,427,700 shares worth $234M. The position accounts for 0.02% of the portfolio, ranked #636.

JP Morgan Chase first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.94B in Q4 2016. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • JP Morgan Chase held 3,427,700 shares of MetLife worth $234M as of Q1 2026.
  • JP Morgan Chase sold 327,988 MetLife shares in Q1 2026, an estimated $24.6M.
  • MetLife made up 0.02% of JP Morgan Chase's portfolio in Q1 2026, its #636 holding.
  • JP Morgan Chase first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • JP Morgan Chase's MetLife position peaked at $1.94B in Q4 2016.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.